Citadel Advisors
MGNX icon

Citadel Advisors’s MacroGenics MGNX Stock Holding History

Citadel Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Sell
782,618
-252,535
-24% -$539K ﹤0.01% 5832
2025
Q4 		$1.67M Buy
1,035,153
+541,622
+110% +$852K ﹤0.01% 6283
2025
Q3 		$829K Buy
493,531
+321,953
+188% +$521K ﹤0.01% 7953
2025
Q2 		$208K Buy
+171,578
New +$249K ﹤0.01% 10599
2024
Q3 		– Sell
-18,569
Closed -$72.3K – 14840
2024
Q2 		$78.9K Sell
18,569
-345,665
-95% -$3.37M ﹤0.01% 11230
2024
Q1 		$5.36M Buy
364,234
+181,750
+100% +$2.75M ﹤0.01% 3851
2023
Q4 		$1.76M Buy
182,484
+71,902
+65% +$497K ﹤0.01% 5597
2023
Q3 		$515K Sell
110,582
-135,722
-55% -$676K ﹤0.01% 8009
2023
Q2 		$1.32M Sell
246,304
-2,668
-1% -$16.5K ﹤0.01% 5909
2023
Q1 		$1.79M Sell
248,972
-208,072
-46% -$1.25M ﹤0.01% 5607
2022
Q4 		$3.07M Sell
457,044
-7,985
-2% -$43.8K ﹤0.01% 4715
2022
Q3 		$1.61M Sell
465,029
-627,420
-57% -$2.4M ﹤0.01% 6014
2022
Q2 		$3.22M Buy
1,092,449
+984,387
+911% +$5.17M ﹤0.01% 4627
2022
Q1 		$952K Buy
108,062
+36,908
+52% +$407K ﹤0.01% 7819
2021
Q4 		$1.14M Sell
71,154
-802,879
-92% -$15.1M ﹤0.01% 7621
2021
Q3 		$18.3M Buy
874,033
+86,255
+11% +$2.08M ﹤0.01% 2138
2021
Q2 		$21.2M Sell
787,778
-1,532,738
-66% -$44.9M ﹤0.01% 2010
2021
Q1 		$73.9M Buy
2,320,516
+679,255
+41% +$16.5M 0.02% 756
2020
Q4 		$37.5M Buy
1,641,261
+1,068,686
+187% +$24.6M 0.01% 1198
2020
Q3 		$14.4M Buy
572,575
+250,096
+78% +$6.83M ﹤0.01% 1876
2020
Q2 		$9M Buy
322,479
+11,084
+4% +$193K ﹤0.01% 2346
2020
Q1 		$1.81M Buy
311,395
+61,864
+25% +$562K ﹤0.01% 4307
2019
Q4 		$2.71M Sell
249,531
-148,802
-37% -$1.47M ﹤0.01% 3932
2019
Q3 		$5.08M Buy
398,333
+377,984
+1,858% +$5.44M ﹤0.01% 3091
2019
Q2 		$346K Sell
20,349
-590,094
-97% -$10.1M ﹤0.01% 7370
2019
Q1 		$11M Buy
610,443
+511,876
+519% +$8.85M 0.01% 1949
2018
Q4 		$1.25M Buy
+98,567
New +$1.65M ﹤0.01% 4952
2018
Q3 		– Sell
-134,173
Closed -$2.77M – 9521
2018
Q2 		$2.77M Buy
134,173
+35,043
+35% +$789K ﹤0.01% 3606
2018
Q1 		$2.49M Buy
99,130
+43,101
+77% +$1.05M ﹤0.01% 3401
2017
Q4 		$1.06M Sell
56,029
-29,898
-35% -$558K ﹤0.01% 4572
2017
Q3 		$1.59M Buy
85,927
+30,594
+55% +$530K ﹤0.01% 3693
2017
Q2 		$969K Sell
55,333
-66,006
-54% -$1.26M ﹤0.01% 4124
2017
Q1 		$2.26M Buy
121,339
+61
+0.1% +$1.18K ﹤0.01% 2939
2016
Q4 		$2.48M Buy
121,278
+107,610
+787% +$2.71M ﹤0.01% 2704
2016
Q3 		$409K Sell
13,668
-13,866
-50% -$412K ﹤0.01% 5172
2016
Q2 		$743K Sell
27,534
-65,452
-70% -$1.48M ﹤0.01% 3955
2016
Q1 		$1.74M Buy
92,986
+84,174
+955% +$1.6M ﹤0.01% 2796
2015
Q4 		$273K Sell
8,812
-8,707
-50% -$265K ﹤0.01% 5356
2015
Q3 		$375K Buy
17,519
+9,532
+119% +$299K ﹤0.01% 5231
2015
Q2 		$303K Buy
+7,987
New +$262K ﹤0.01% 5723
2015
Q1 		– Sell
-58,834
Closed -$2.06M – 8716
2014
Q4 		$2.06M Sell
58,834
-20,640
-26% -$515K ﹤0.01% 2877
2014
Q3 		$1.66M Buy
79,474
+27,968
+54% +$578K ﹤0.01% 3075
2014
Q2 		$1.12M Sell
51,506
-48,813
-49% -$1.03M ﹤0.01% 3359
2014
Q1 		$2.79M Buy
+100,319
New +$3.54M ﹤0.01% 2296

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Citadel Advisors's MGNX Position: Q1 2026 in Review

Citadel Advisors reduced its MacroGenics (MGNX) stake by 24% in Q1 2026, selling an estimated $539K and leaving 782,618 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #5832.

Citadel Advisors first reported a position in MGNX in Q1 2014 and has held it in 44 quarters since. The position peaked at $73.9M in Q1 2021. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Citadel Advisors held 782,618 shares of MacroGenics worth $2.26M as of Q1 2026.
  • Citadel Advisors sold 252,535 MacroGenics shares in Q1 2026, an estimated $539K.
  • MacroGenics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5832 holding.
  • Citadel Advisors first reported a position in MacroGenics in Q1 2014 and has held it in 44 quarters since.
  • Citadel Advisors's MacroGenics position peaked at $73.9M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.